3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Multiple Myeloma
238
Precursor Cell Lymphoblastic Leukemia-Lymphoma
46
Recurrence
35
Burkitt Lymphoma
23
Neoplasms
20
Neoplasms, Plasma Cell
17
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
15
Immunoglobulin Light-chain Amyloidosis
13
Leukemia
12
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
10
Lymphoma
10
Lymphoma, Large B-Cell, Diffuse
9
Lung Neoplasms
9
Carcinoma, Non-Small-Cell Lung
9
Prostatic Neoplasms
8
Leukemia, Biphenotypic, Acute
8
Neoplasm Metastasis
7
Lymphoma, Non-Hodgkin
7
Breast Neoplasms
7
Lymphoma, B-Cell
6
Smoldering Multiple Myeloma
5
Nausea
5
Leukemia, Myeloid, Acute
5
Hodgkin Disease
5
Brain Neoplasms
5
Waldenstrom Macroglobulinemia
4
Neoplasm, Residual
4
Lymphoma, T-Cell, Peripheral
4
Lymphoma, Mantle-Cell
4
Amyloidosis
4
Interventions
Cyclophosphamide
16
Mycophenolic Acid
13
Tacrolimus
10
fludarabine
9
ruxolitinib
8
Busulfan
7
fludarabine phosphate
6
Whole-Body Irradiation
6
Sirolimus
6
Melphalan
6
Methotrexate
5
Thiotepa
4
ibrutinib
3
Specimen Handling
3
Cyclosporine
3
Abatacept
3
Stem Cell Transplantation
2
Radiotherapy
2
Hematopoietic Stem Cell Transplantation
2
Clofarabine
2
Biopsy
2
vedolizumab
1
tildrakizumab
1
itacitinib
1
blinatumomab
1
belumosudil
1
axatilimab
1
Vorinostat
1
Therapeutics
1
Rituximab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Graft vs Host Disease
×
Dexamethasone
×
1 year
×
Clear all
No trials found.